nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanol—CYP1A1—Clobetasol propionate—psoriasis	0.162	0.178	CbGbCtD
Ethanol—CYP4A11—Dexamethasone—psoriasis	0.134	0.147	CbGbCtD
Ethanol—CYP1A1—Methoxsalen—psoriasis	0.0851	0.0935	CbGbCtD
Ethanol—CYP1A2—Clobetasol propionate—psoriasis	0.0724	0.0795	CbGbCtD
Ethanol—CYP1A1—Cholecalciferol—psoriasis	0.0564	0.0619	CbGbCtD
Ethanol—CYP2B6—Cholecalciferol—psoriasis	0.043	0.0472	CbGbCtD
Ethanol—CYP1A2—Methoxsalen—psoriasis	0.038	0.0418	CbGbCtD
Ethanol—CYP2C19—Cholecalciferol—psoriasis	0.0273	0.03	CbGbCtD
Ethanol—CYP3A4—Calcitriol—psoriasis	0.0256	0.0281	CbGbCtD
Ethanol—CYP1A1—Dexamethasone—psoriasis	0.0244	0.0268	CbGbCtD
Ethanol—CYP2C9—Cholecalciferol—psoriasis	0.0227	0.0249	CbGbCtD
Ethanol—CYP3A4—Methoxsalen—psoriasis	0.0199	0.0219	CbGbCtD
Ethanol—CYP2C19—Prednisone—psoriasis	0.0189	0.0208	CbGbCtD
Ethanol—CYP2E1—Dexamethasone—psoriasis	0.0188	0.0207	CbGbCtD
Ethanol—CYP2B6—Dexamethasone—psoriasis	0.0186	0.0204	CbGbCtD
Ethanol—CYP2C19—Cyclosporine—psoriasis	0.0179	0.0197	CbGbCtD
Ethanol—CYP2C9—Cyclosporine—psoriasis	0.0149	0.0164	CbGbCtD
Ethanol—CYP3A4—Cholecalciferol—psoriasis	0.0132	0.0145	CbGbCtD
Ethanol—CYP2C19—Dexamethasone—psoriasis	0.0118	0.013	CbGbCtD
Ethanol—CYP3A4—Mycophenolate mofetil—psoriasis	0.0114	0.0126	CbGbCtD
Ethanol—CYP3A4—Triamcinolone—psoriasis	0.0114	0.0126	CbGbCtD
Ethanol—CYP2C9—Dexamethasone—psoriasis	0.00982	0.0108	CbGbCtD
Ethanol—CYP3A4—Betamethasone—psoriasis	0.00982	0.0108	CbGbCtD
Ethanol—CYP3A4—Prednisolone—psoriasis	0.00969	0.0106	CbGbCtD
Ethanol—CYP3A4—Hydrocortisone—psoriasis	0.00918	0.0101	CbGbCtD
Ethanol—CYP3A4—Prednisone—psoriasis	0.00915	0.01	CbGbCtD
Ethanol—CYP3A4—Cyclosporine—psoriasis	0.00867	0.00953	CbGbCtD
Ethanol—CYP4A11—Miscellaneous substrates—CYP2S1—psoriasis	0.00643	0.0717	CbGpPWpGaD
Ethanol—CYP3A4—Dexamethasone—psoriasis	0.00571	0.00627	CbGbCtD
Ethanol—ADH1B—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00476	0.0532	CbGpPWpGaD
Ethanol—ADH1C—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00476	0.0532	CbGpPWpGaD
Ethanol—ADH1A—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00395	0.0441	CbGpPWpGaD
Ethanol—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00296	0.033	CbGpPWpGaD
Ethanol—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.0029	0.0324	CbGpPWpGaD
Ethanol—ADH1B—Biological oxidations—CYP2S1—psoriasis	0.00253	0.0282	CbGpPWpGaD
Ethanol—ADH1C—Biological oxidations—CYP2S1—psoriasis	0.00253	0.0282	CbGpPWpGaD
Ethanol—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00224	0.025	CbGpPWpGaD
Ethanol—ADH1A—Biological oxidations—CYP2S1—psoriasis	0.0021	0.0234	CbGpPWpGaD
Ethanol—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00204	0.0228	CbGpPWpGaD
Ethanol—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00184	0.0205	CbGpPWpGaD
Ethanol—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.0018	0.0201	CbGpPWpGaD
Ethanol—CYP4A11—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00177	0.0198	CbGpPWpGaD
Ethanol—CYP4A11—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00175	0.0195	CbGpPWpGaD
Ethanol—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.00169	0.0189	CbGpPWpGaD
Ethanol—CYP4A11—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00144	0.016	CbGpPWpGaD
Ethanol—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00139	0.0155	CbGpPWpGaD
Ethanol—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00126	0.0141	CbGpPWpGaD
Ethanol—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.00108	0.0121	CbGpPWpGaD
Ethanol—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000834	0.00931	CbGpPWpGaD
Ethanol—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000815	0.00909	CbGpPWpGaD
Ethanol—CYP4A11—Biological oxidations—CYP2S1—psoriasis	0.000764	0.00852	CbGpPWpGaD
Ethanol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000762	0.0085	CbGpPWpGaD
Ethanol—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000752	0.00839	CbGpPWpGaD
Ethanol—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000746	0.00833	CbGpPWpGaD
Ethanol—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000737	0.00822	CbGpPWpGaD
Ethanol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000704	0.00785	CbGpPWpGaD
Ethanol—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000695	0.00775	CbGpPWpGaD
Ethanol—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000618	0.00689	CbGpPWpGaD
Ethanol—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000605	0.00675	CbGpPWpGaD
Ethanol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000576	0.00643	CbGpPWpGaD
Ethanol—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000571	0.00637	CbGpPWpGaD
Ethanol—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000568	0.00634	CbGpPWpGaD
Ethanol—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000568	0.00634	CbGpPWpGaD
Ethanol—CYP4A11—PPARA activates gene expression—CARM1—psoriasis	0.000533	0.00595	CbGpPWpGaD
Ethanol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000525	0.00586	CbGpPWpGaD
Ethanol—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000522	0.00582	CbGpPWpGaD
Ethanol—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000518	0.00578	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—NDUFA5—psoriasis	0.000509	0.00568	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—NDUFA5—psoriasis	0.000509	0.00568	CbGpPWpGaD
Ethanol—GLRA2—Transmembrane transport of small molecules—CP—psoriasis	0.000493	0.00551	CbGpPWpGaD
Ethanol—GLRA2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000471	0.00525	CbGpPWpGaD
Ethanol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000467	0.00521	CbGpPWpGaD
Ethanol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000449	0.00501	CbGpPWpGaD
Ethanol—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000443	0.00494	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—CYP2S1—psoriasis	0.000433	0.00483	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—CYP2S1—psoriasis	0.000433	0.00483	CbGpPWpGaD
Ethanol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000426	0.00475	CbGpPWpGaD
Ethanol—CYP4A11—NRF2 pathway—TGFA—psoriasis	0.000425	0.00474	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—NDUFA5—psoriasis	0.000422	0.00471	CbGpPWpGaD
Ethanol—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000368	0.00411	CbGpPWpGaD
Ethanol—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000364	0.00406	CbGpPWpGaD
Ethanol—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.00036	0.00401	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—CYP2S1—psoriasis	0.000359	0.004	CbGpPWpGaD
Ethanol—GABRA1—Orphan transporters—CARM1—psoriasis	0.000352	0.00393	CbGpPWpGaD
Ethanol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00035	0.00391	CbGpPWpGaD
Ethanol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000346	0.00386	CbGpPWpGaD
Ethanol—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000345	0.00385	CbGpPWpGaD
Ethanol—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000343	0.00383	CbGpPWpGaD
Ethanol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000342	0.00381	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000338	0.00377	CbGpPWpGaD
Ethanol—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000328	0.00366	CbGpPWpGaD
Ethanol—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000324	0.00361	CbGpPWpGaD
Ethanol—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000321	0.00359	CbGpPWpGaD
Ethanol—GLRA1—Transmembrane transport of small molecules—CP—psoriasis	0.000318	0.00355	CbGpPWpGaD
Ethanol—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000317	0.00354	CbGpPWpGaD
Ethanol—GLRA1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000303	0.00338	CbGpPWpGaD
Ethanol—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000303	0.00338	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.0003	0.00334	CbGpPWpGaD
Ethanol—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000299	0.00333	CbGpPWpGaD
Ethanol—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000298	0.00333	CbGpPWpGaD
Ethanol—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000294	0.00328	CbGpPWpGaD
Ethanol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000281	0.00313	CbGpPWpGaD
Ethanol—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000277	0.00309	CbGpPWpGaD
Ethanol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000277	0.00309	CbGpPWpGaD
Ethanol—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000261	0.00292	CbGpPWpGaD
Ethanol—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000248	0.00277	CbGpPWpGaD
Ethanol—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000245	0.00273	CbGpPWpGaD
Ethanol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000244	0.00272	CbGpPWpGaD
Ethanol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000241	0.00269	CbGpPWpGaD
Ethanol—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.00024	0.00268	CbGpPWpGaD
Ethanol—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000239	0.00267	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000237	0.00264	CbGpPWpGaD
Ethanol—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000226	0.00252	CbGpPWpGaD
Ethanol—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000223	0.00249	CbGpPWpGaD
Ethanol—CYP4A11—PPARA activates gene expression—PPARG—psoriasis	0.000222	0.00248	CbGpPWpGaD
Ethanol—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.00022	0.00245	CbGpPWpGaD
Ethanol—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000217	0.00242	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000215	0.0024	CbGpPWpGaD
Ethanol—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000212	0.00236	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—CARM1—psoriasis	0.000211	0.00236	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—CARM1—psoriasis	0.000211	0.00236	CbGpPWpGaD
Ethanol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000207	0.00231	CbGpPWpGaD
Ethanol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000206	0.0023	CbGpPWpGaD
Ethanol—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000193	0.00216	CbGpPWpGaD
Ethanol—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000191	0.00213	CbGpPWpGaD
Ethanol—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.00019	0.00212	CbGpPWpGaD
Ethanol—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000187	0.00209	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—CARM1—psoriasis	0.000175	0.00195	CbGpPWpGaD
Ethanol—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000175	0.00195	CbGpPWpGaD
Ethanol—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.00017	0.0019	CbGpPWpGaD
Ethanol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000168	0.00188	CbGpPWpGaD
Ethanol—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000167	0.00186	CbGpPWpGaD
Ethanol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000159	0.00177	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—NDUFA5—psoriasis	0.000154	0.00171	CbGpPWpGaD
Ethanol—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.00015	0.00167	CbGpPWpGaD
Ethanol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000149	0.00166	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	0.000148	0.00165	CbGpPWpGaD
Ethanol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000147	0.00164	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000145	0.00162	CbGpPWpGaD
Ethanol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000144	0.0016	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000143	0.0016	CbGpPWpGaD
Ethanol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000143	0.0016	CbGpPWpGaD
Ethanol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000143	0.00159	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—CYP2S1—psoriasis	0.000131	0.00146	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—CAT—psoriasis	0.00013	0.00145	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—CAT—psoriasis	0.00013	0.00145	CbGpPWpGaD
Ethanol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000129	0.00144	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000126	0.0014	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000121	0.00135	CbGpPWpGaD
Ethanol—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000111	0.00124	CbGpPWpGaD
Ethanol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000111	0.00124	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.00011	0.00122	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—CAT—psoriasis	0.000108	0.0012	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—APOE—psoriasis	0.000101	0.00113	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—APOE—psoriasis	0.000101	0.00113	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.4e-05	0.00105	CbGpPWpGaD
Ethanol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.4e-05	0.00105	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	9.26e-05	0.00103	CbGpPWpGaD
Ethanol—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	9.02e-05	0.00101	CbGpPWpGaD
Ethanol—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	8.81e-05	0.000983	CbGpPWpGaD
Ethanol—ADH1C—Metabolism—PPARG—psoriasis	8.8e-05	0.000982	CbGpPWpGaD
Ethanol—ADH1B—Metabolism—PPARG—psoriasis	8.8e-05	0.000982	CbGpPWpGaD
Ethanol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	8.62e-05	0.000962	CbGpPWpGaD
Ethanol—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	8.61e-05	0.00096	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—APOE—psoriasis	8.37e-05	0.000934	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	8.09e-05	0.000903	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	8e-05	0.000893	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	7.7e-05	0.000859	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	7.52e-05	0.000839	CbGpPWpGaD
Ethanol—ADH1A—Metabolism—PPARG—psoriasis	7.29e-05	0.000814	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	7.24e-05	0.000808	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.99e-05	0.00078	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.84e-05	0.000764	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—NDUFA5—psoriasis	6.6e-05	0.000736	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	6.57e-05	0.000733	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—NDUFA5—psoriasis	6.46e-05	0.000721	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—CARM1—psoriasis	6.38e-05	0.000712	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—NDUFA5—psoriasis	6.1e-05	0.00068	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.99e-05	0.000669	CbGpPWpGaD
Ethanol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.99e-05	0.000669	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.96e-05	0.000665	CbGpPWpGaD
Ethanol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	5.94e-05	0.000663	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.68e-05	0.000634	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	5.63e-05	0.000629	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—CYP2S1—psoriasis	5.61e-05	0.000626	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—CYP2S1—psoriasis	5.5e-05	0.000613	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—CYP2S1—psoriasis	5.18e-05	0.000578	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—NDUFA5—psoriasis	4.99e-05	0.000557	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.65e-05	0.000519	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—NDUFA5—psoriasis	4.55e-05	0.000507	CbGpPWpGaD
Ethanol—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	4.55e-05	0.000507	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—CYP2S1—psoriasis	4.24e-05	0.000473	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.24e-05	0.000473	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—CAT—psoriasis	3.92e-05	0.000438	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—NDUFA5—psoriasis	3.89e-05	0.000434	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—CYP2S1—psoriasis	3.87e-05	0.000431	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.62e-05	0.000404	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—CYP2S1—psoriasis	3.3e-05	0.000369	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—APOE—psoriasis	3.05e-05	0.00034	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—NDUFA5—psoriasis	3e-05	0.000335	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—CARM1—psoriasis	2.74e-05	0.000306	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.72e-05	0.000303	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—CARM1—psoriasis	2.68e-05	0.0003	CbGpPWpGaD
Ethanol—CYP4A11—Metabolism—PPARG—psoriasis	2.65e-05	0.000296	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—CYP2S1—psoriasis	2.55e-05	0.000285	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—CARM1—psoriasis	2.53e-05	0.000282	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.37e-05	0.000264	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.22e-05	0.000248	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—CARM1—psoriasis	2.07e-05	0.000231	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.03e-05	0.000226	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.94e-05	0.000216	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—CARM1—psoriasis	1.89e-05	0.000211	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.77e-05	0.000197	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.000193	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—CAT—psoriasis	1.69e-05	0.000188	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—CAT—psoriasis	1.65e-05	0.000184	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—CARM1—psoriasis	1.61e-05	0.00018	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—CAT—psoriasis	1.56e-05	0.000174	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.51e-05	0.000168	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—APOE—psoriasis	1.31e-05	0.000146	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—APOE—psoriasis	1.28e-05	0.000143	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—CAT—psoriasis	1.27e-05	0.000142	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—CARM1—psoriasis	1.25e-05	0.000139	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—APOE—psoriasis	1.21e-05	0.000135	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—CAT—psoriasis	1.16e-05	0.00013	CbGpPWpGaD
Ethanol—CYP2B6—Metabolism—PPARG—psoriasis	1.14e-05	0.000127	CbGpPWpGaD
Ethanol—CYP2E1—Metabolism—PPARG—psoriasis	1.12e-05	0.000125	CbGpPWpGaD
Ethanol—CYP1A1—Metabolism—PPARG—psoriasis	1.05e-05	0.000118	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—CAT—psoriasis	9.93e-06	0.000111	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—APOE—psoriasis	9.9e-06	0.00011	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—APOE—psoriasis	9.03e-06	0.000101	CbGpPWpGaD
Ethanol—CYP2C19—Metabolism—PPARG—psoriasis	8.62e-06	9.62e-05	CbGpPWpGaD
Ethanol—CYP2C9—Metabolism—PPARG—psoriasis	7.86e-06	8.77e-05	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—APOE—psoriasis	7.71e-06	8.61e-05	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—CAT—psoriasis	7.66e-06	8.55e-05	CbGpPWpGaD
Ethanol—CYP1A2—Metabolism—PPARG—psoriasis	6.72e-06	7.5e-05	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—APOE—psoriasis	5.95e-06	6.64e-05	CbGpPWpGaD
Ethanol—CYP3A4—Metabolism—PPARG—psoriasis	5.18e-06	5.78e-05	CbGpPWpGaD
